Plasma vitamin D levels and vitamin D receptor polymorphisms are associated with survival of non-small cell lung cancer

Chinese Journal of Cancer Research

Volumn 23, Issue 1, 2011, Pages 33-37

  Liu, Yao ^a   Chen, Wei ^a   Hu, Zhi Bin ^a,c   Xu, Lin ^b   Shu, Yong Qian ^a   Pan, Shi Yang ^a   Dai, Jun Cheng ^a   Jin, Guang Fu ^a,c   Ma, Hong Xia ^a   Shen, Hong Bing ^a,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c Prevention and Treatment   (China)

Author keywords

Chinese population; Non small cell lung cancer; Prognosis; Vitamin D receptor polymorphisms

Indexed keywords

25 HYDROXYVITAMIN D; TUMOR MARKER; VITAMIN D RECEPTOR;

ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHINESE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PROGNOSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL;

EID: 79953213348     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-011-0033-3     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Gönen M, Weiser MR. Whither TNM? Semin Oncol 2010; 37:27-30.
3. Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005; 5:845-56. (Pubitemid 41746029)
4. Kulie T, Groff A, Redmer J, et al. Vitamin D: an evidence-based review. J Am Board Fam Med 2009; 22:698-706.
5. Ali MM, Vaidya V. Vitamin D and cancer. J Cancer Res Ther 2007; 3:225-30.
6. Srinivasan M, Parwani AV, Hershberger PA, et al. Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer. J Steroid Biochem Mol Biol 2011; 123:30-6.
7. Güzey M, Sattler C, DeLuca HF. Combinational effects of vitamin D3 and retinoic acid (all trans and 9 cis) on proliferation, differentiation, and programmed cell death in two small cell lung carcinoma cell lines. Biochem Biophys Res Commun 1998; 249:735-44. (Pubitemid 28441909)
8. Freedman DM, Looker AC, Abnet CC, et al. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 2010; 70:8587-97.
9. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97.
10. Obi-Tabot ET, Tian XQ, Chen TC, et al. A human skin equivalent model that mimics the photoproduction of vitamin D3 in human skin. In Vitro Cell Dev Biol Anim 2000; 36:201-4. (Pubitemid 30193768)
11. Torres C, de la Torre MS, Garcia-Moruja C, et al. Immunophenotype of Vitamin D Receptor Polymorphism Associated to Risk of HIV-1 Infection and Rate of Disease Progression. Curr HIV Res 2010; 8: 487-92.
12. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338:143-56. (Pubitemid 39094759)
13. Arai H, Miyamoto KI, Yoshida M, et al. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res 2001; 16:1256-64. (Pubitemid 32574654)
14. Zhou W, Heist RS, Liu G, et al. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2006; 15:2239-45. (Pubitemid 44877051)
15. Heist RS, Zhou W, Wang Z, et al. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 2008; 26:5596-602.
16. Lundin AC, Söderkvist P, Eriksson B, et al. Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 1999; 59:2332-4. (Pubitemid 29242278)
17. Huang SP, Huang CY, Wu WJ, et al. Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy. Int J Cancer 2006; 119:1902-7.
18. Hu Z, Wang H, Shao M, et al. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis. Hum Mutat 2007; 28:431-40. (Pubitemid 46668601)
19. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 2008; 26:2984-91.
20. Tamez S, Norizoe C, Ochiai K, et al. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 2009; 101:1957-60.
21. Zhang M, Hu Z, Huang J, et al. A 3′-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population. Clin Cancer Res 2010; 16:1236-44.
22. Goodwin PJ, Ennis M, Pritchard KI, et al. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009; 27:3757-63.